What the FDA labels say about taking them together
Acellular tissue engineered vessel and clopidogrel
Acellular tissue engineered vessel's FDA label of December 9, 2025 names clopidogrel in its contraindications section; the clopidogrel label PlainMeds reads does not name acellular tissue engineered vessel. The acellular tissue engineered vessel label: “CONTRAINDICATIONS DO NOT use SYMVESS in patients who have a medical condition that would preclude long-term antiplatelet therapy after resolution of acute injuries.”
Check it at the source: the acellular tissue engineered vessel FDA label on DailyMed (effective December 9, 2025); the clopidogrel FDA label on DailyMed (effective May 30, 2025, Sanofi-Aventis U.S. LLC).
What does the acellular tissue engineered vessel label say about clopidogrel?
Acellular tissue engineered vessel label, contraindicationsCONTRAINDICATIONS DO NOT use SYMVESS in patients who have a medical condition that would preclude long-term antiplatelet therapy (such as aspirin or clopidogrel) after resolution of acute injuries.
Source: FDA drug label (Symvess), Humacyte Global, Inc., effective December 9, 2025 (SPL set 15e9e29f-5aa6-4fc6-b0fe-a48cd1473418), via openFDA; the full label on DailyMed
What does the clopidogrel label say about acellular tissue engineered vessel?
Clopidogrel's label (effective May 30, 2025) does not name acellular tissue engineered vessel in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Plavix), Sanofi-Aventis U.S. LLC, effective May 30, 2025 (SPL set de8b0b67-eb25-4684-83b5-7ad785314227), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Acellular tissue engineered vessel | Clopidogrel | |
|---|---|---|
| Labeled for | n/a | Heart attack and coronary artery disease, Angina |
| Boxed warning | Yes | Yes |
| Pharmacy cost (NADAC) | n/a | $0.0472 per tablet 75 mg tablet |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once